Korean Analysts Retain Optimism For Daewoong Pharmaceutical On Early Pipeline and In-licensing

SEOUL - Daewoong Pharmaceutical has beefed up its product lineup and increased R&D investment for high-growth therapeutic areas, which has brightened the company's outlook in the eyes of some Korean analysts despite stronger generics competition in 2011